3186 results for «3558»

Filter By

3186 results

Hotline TAVI 2: outcomes with new and established devices

21 May 2025 – From EuroPCR 2025

Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Hotline TAVI 2: outcomes with new and established devices

Novel tools and strategies in chronic heart failure

21 May 2025 – From EuroPCR 2025

Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...

Novel tools and strategies in chronic heart failure

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Multi-modality assessment of coronary disease

21 May 2025 – From EuroPCR 2025

This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...

Multi-modality assessment of coronary disease

Iatrogenic causes for shock treated with LV support

21 May 2025 – From EuroPCR 2025

Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.

Iatrogenic causes for shock treated with LV support

Major Late-Breaking Trials from EuroPCR 2025

21 May 2025 – From EuroPCR 2025

Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...

Major Late-Breaking Trials from EuroPCR 2025

Treatment dilemmas in STEMI patients with multivessel disease

21 May 2025 – From EuroPCR 2025

Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.

Treatment dilemmas in STEMI patients with multivessel disease

Stent technologies, last evidence in coronary interventions

21 May 2025 – From EuroPCR 2025

Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...

Stent technologies, last evidence in coronary interventions

Case-based learning on different aspects of transcatheter LAA closure

21 May 2025 – From EuroPCR 2025

Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.

Case-based learning on different aspects of transcatheter LAA closure

Choices, choices: a global perspective on multiple modalities for calcium modification

21 May 2025 – From EuroPCR 2025

Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...

Choices, choices: a global perspective on multiple modalities for calcium modification

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

Novel devices for edge-to-edge mitral repair

21 May 2025 – From EuroPCR 2025

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

Novel devices for edge-to-edge mitral repair

Coronary scaffolds: new developments and applications

21 May 2025 – From EuroPCR 2025

Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.

Coronary scaffolds: new developments and applications

DCB PCI: are we ready for complex de novo lesions?

21 May 2025 – From EuroPCR 2025

Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...

DCB PCI: are we ready for complex de novo lesions?

DES and bioadaptator technologies in contemporary practice

21 May 2025 – From EuroPCR 2025

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...

DES and bioadaptator technologies in contemporary practice

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

Valve-in-valve TAVI

21 May 2025 – From EuroPCR 2025

Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.

Valve-in-valve TAVI

PCR's Got Talent - Round 2 - Session 1

21 May 2025 – From EuroPCR 2025

PCR's Got Talent Round 2 Session 1 showcases emerging talents and innovations in interventional cardiology, highlighting promising advancements and expert insights shaping the future of cardiovascular interventions.

PCR's Got Talent - Round 2 - Session 1
Didn’t find what you were looking for?